- Home
- SVRA vs EQV Comparison
SVRA vs EQV Comparison
Compare SVRA & EQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVRA
- EQV
- Stock Information
- Founded
- SVRA N/A
- EQV 2024
- Country
- SVRA United States
- EQV United States
- Employees
- SVRA N/A
- EQV N/A
- Industry
- SVRA Biotechnology: Pharmaceutical Preparations
- EQV
- Sector
- SVRA Health Care
- EQV
- Exchange
- SVRA Nasdaq
- EQV Nasdaq
- Market Cap
- SVRA 458.2M
- EQV 443.1M
- IPO Year
- SVRA N/A
- EQV 2024
- Fundamental
- Price
- SVRA $2.85
- EQV $10.02
- Analyst Decision
- SVRA Buy
- EQV
- Analyst Count
- SVRA 7
- EQV 0
- Target Price
- SVRA $9.86
- EQV N/A
- AVG Volume (30 Days)
- SVRA 1.0M
- EQV 47.6K
- Earning Date
- SVRA 03-06-2025
- EQV 01-01-0001
- Dividend Yield
- SVRA N/A
- EQV N/A
- EPS Growth
- SVRA N/A
- EQV N/A
- EPS
- SVRA N/A
- EQV N/A
- Revenue
- SVRA N/A
- EQV N/A
- Revenue This Year
- SVRA N/A
- EQV N/A
- Revenue Next Year
- SVRA N/A
- EQV N/A
- P/E Ratio
- SVRA N/A
- EQV N/A
- Revenue Growth
- SVRA N/A
- EQV N/A
- 52 Week Low
- SVRA $2.59
- EQV $9.88
- 52 Week High
- SVRA $5.70
- EQV $10.05
- Technical
- Relative Strength Index (RSI)
- SVRA 45.63
- EQV N/A
- Support Level
- SVRA $2.62
- EQV N/A
- Resistance Level
- SVRA $2.88
- EQV N/A
- Average True Range (ATR)
- SVRA 0.19
- EQV 0.00
- MACD
- SVRA 0.02
- EQV 0.00
- Stochastic Oscillator
- SVRA 40.37
- EQV 0.00
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.
About EQV EQV Ventures Acquisition Corp.
EQV Ventures Acquisition Corp is a blank check company.